Your browser doesn't support javascript.
loading
Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer.
Johmura, Yoshikazu; Maeda, Ichiro; Suzuki, Narumi; Wu, Wenwen; Goda, Atsushi; Morita, Mariko; Yamaguchi, Kiyoshi; Yamamoto, Mizuki; Nagasawa, Satoi; Kojima, Yasuyuki; Tsugawa, Koichiro; Inoue, Natsuko; Miyoshi, Yasuo; Osako, Tomo; Akiyama, Futoshi; Maruyama, Reo; Inoue, Jun-Ichiro; Furukawa, Yoichi; Ohta, Tomohiko; Nakanishi, Makoto.
Afiliação
  • Johmura Y; Division of Cancer Cell Biology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Maeda I; Department of Pathology St. Marianna University School of Medicine, Kawasaki, Japan.
  • Suzuki N; Division of Cancer Cell Biology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Wu W; Department of Translational Oncology, St. Marianna University Graduate School of Medicine, Kawasaki, Japan.
  • Goda A; Department of Pathology St. Marianna University School of Medicine, Kawasaki, Japan.
  • Morita M; Division of Clinical Genome Research, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Yamaguchi K; Division of Clinical Genome Research, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Yamamoto M; Division of Cellular and Molecular Biology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Nagasawa S; Division of Breast and Endocrine Surgery, Department of Surgery, St. Marianna University School of Medicine, Kawasaki, Japan.
  • Kojima Y; Division of Breast and Endocrine Surgery, Department of Surgery, St. Marianna University School of Medicine, Kawasaki, Japan.
  • Tsugawa K; Division of Breast and Endocrine Surgery, Department of Surgery, St. Marianna University School of Medicine, Kawasaki, Japan.
  • Inoue N; Division of Breast and Endocrine Surgery, Department of Surgery, Hyogo College of Medicine, Hyogo, Japan.
  • Miyoshi Y; Division of Breast and Endocrine Surgery, Department of Surgery, Hyogo College of Medicine, Hyogo, Japan.
  • Osako T; Department of Pathology, The Cancer Institute Hospital, and.
  • Akiyama F; Department of Pathology, The Cancer Institute Hospital, and.
  • Maruyama R; Project for Cancer Epigenomics, the Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Inoue JI; Division of Cellular and Molecular Biology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Furukawa Y; Division of Clinical Genome Research, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Ohta T; Department of Translational Oncology, St. Marianna University Graduate School of Medicine, Kawasaki, Japan.
  • Nakanishi M; Division of Cancer Cell Biology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
J Clin Invest ; 128(12): 5603-5619, 2018 12 03.
Article em En | MEDLINE | ID: mdl-30418174
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores Citoplasmáticos e Nucleares / Proteínas F-Box / Receptor alfa de Estrogênio / Histona Desmetilases com o Domínio Jumonji / Proteólise / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: J Clin Invest Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores Citoplasmáticos e Nucleares / Proteínas F-Box / Receptor alfa de Estrogênio / Histona Desmetilases com o Domínio Jumonji / Proteólise / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: J Clin Invest Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão